Investment Stage

Focus Areas

About Investor

Julia Salaverria is the Managing Partner at Ysios Capital, a leading Spanish independent venture capital firm that provides private equity financing to early and mid-stage life science companies. The firm focuses on BioTech, Medical Devices, and Digital Health sectors at Series A, Series B, Series C, and Series D stages, with investment ranges typically between €5 million and €20 million. Julia has over 25 years of experience in executive roles and is responsible for investor relations and corporate development and management at Ysios Capital, leading investments in biotech ventures developing novel drugs across diverse therapeutic areas.